Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

from The Long Run with Luke Timmerman · host Timmerman Report

Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.

Episode metadata supplied by the publisher feed · Published Feb 9, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

0:00 1:03:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 3 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on February 9, 2024.

Can I download this The Long Run with Luke Timmerman episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!